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Problem Identification
Chronic venous disease (CVD) is commonly assessed using the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification
Chronic Venous Insufficiency (CVI) is characterized as patients with more advanced clinical signs of CVD (C3-C6)
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Problem Identification
 CVI skin changes in western countries range from <1%-40% in women and <1%-17% in men2
 Progression to stasis dermatitis (C4) is most common in people >50 years old in the USA with an overall disease
prevalence of 6-7%3 in patients >50 years old
 In Vermont, 18.1% of people are >65 years old and specifically in Bennington County 22.1% of people are >65
years, demonstrating a large population at risk of developing or actively managing stasis dermatitis without
taking into account people ages 50-654



One study found an association between symptoms of venous insufficiency and increased BMI in people from
Burlington, Vermont and Leiden, Netherlands5
In Vermont, 56% of the population >45 years old are considered obese6 and in Bennington County 24.1%7 of the
total population are considered obese, thus further increasing the risk of these populations developing or
managing stasis dermatitis

 According to the AAFP8, the prevalence of venous stasis ulcers (C5-C6) is 1% in the USA, and of people in the USA
affected by venous stasis ulcers, the recurrence rate is 72% 9
 Complications of venous ulcers include osteomyelitis, cellulitis and malignant changes, thus developing venous
stasis ulcers significantly increases a patient’s mortality rate10,11

 Key Problem:
• The complications of stasis dermatitis including venous ulcers, osteomyelitis, and cellulitis all
significantly increase morbidity and mortality of disease
• Progression beyond stasis dermatitis and avoidance of the aforementioned complications are
preventable with patient education and adherence to basic therapies including compression
stockings and lifestyle modification
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 Therefore, the questions needing to be addressed are: (1) What is our patients’ understanding of stasis dermatitis? (2) Are they aware of the
complications associated with disease progression? (3) Do they know when to come see a provider for worsening symptoms of venous insufficiency beyond
stasis dermatitis? (4) What are the barriers to treating stasis dermatitis and preventing disease progression?
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Public Health Cost
 Estimated financial burden of $1.9-2.5 billion dollars per year in the USA for venous stasis ulcers9,12
 Average total medical cost of $9685 per patient for 3 months of venous stasis ulcer treatment9

 In 2016, Vermont had 135,668 total Medicare beneficiaries (22% of total VT population)13
 This is higher than the national average (18%) of Medicare beneficiaries as a percent of the total population

 The financial burden of progression of CVI beyond stasis dermatitis is an enormous Medicare expense since people >50 years old are
predominantly affected
 In 2016, there were 9,116 Bennington County beneficiaries of Medicare13 which was 25% of the Bennington County population
 This has increased from 8,591 Bennington County beneficiaries of Medicare in 2014,14 which was 24% of the Bennington County population

 As of 2014, in Bennington County the standardized risk-adjusted per capita Medicare cost was $8,473.1514 which is higher than the majority
of counties in Vermont
 Medicare does not cover compression stockings/garments in their insurance plan, limiting access to an affordable preventative therapy
(2014)

Thus, there is a large proportion of Medicare dollars being
spent on CVI beyond stasis dermatitis which could be saved
with relatively inexpensive interventions including
compression stockings, exercise, and weight loss. Through
preventative measures, expanded insurance coverage, and
appropriate management of stasis dermatitis prior to venous
ulcer formation we can decrease the burden of cost in
Bennington County, Vermont, and nationwide.

(2014)

Bennington County

3

Community Perspectives
Maggie Dusha, ANP FNP

Dr. Marisa Friscia, MD

Kate Lawrence, MSN BSN RN

Margaret Heale, WOCN

Battenkill Valley Health Center Provider

Battenkill Valley Health Center Provider

Director of Home Care, VNA & Hospice of
Southwest Region of Vermont

Heale Wound Care WTA program course:
Private WOC Consulting

Do your patients understand the potential consequences of stasis dermatitis?
“I don’t [think so] because patients
who have had this for a long time
look at this [stasis dermatitis] as their
norm.”

“I try to explain it to them but the
truth is, is that most patients don’t
understand it.”

“For the most part the patients are
unaware across the board unless they
have had nursing interventions
before.”

“No I don’t think they do generally
speaking. People don’t seem to
appreciate that covering up a
problem, such as with trousers,
doesn’t get rid of that problem.”

Do you think your patients understand when to come see their provider for worsening symptoms of venous insufficiency beyond stasis
dermatitis?
“Not always, they don’t realize the
severity and complications that can
occur. They say ‘it will heal on its
own’ if they have a venous ulcer
developing. They typically initially try
to manage the symptoms
themselves, but they will come in
with increased drainage, pain, and
redness around the lesion.”

“If they have had it for a while with
recurrent symptoms then yes they
do, but not initially. If they have had
multiple episodes of treatment with
improvement, then they will return
with worsening symptoms.”

“No, overall patients have no clue.
They know their legs get big and their
shoes don’t fit but they won’t start
going to see a provider unless it is
painful, they have an ulcer, or a
provider picks it up in the office.”
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“Most people don’t see discoloration
or itching as something that will take
them to the doctor’s office. Also,
many people don’t have a primary
care provider at all because they
either want to avoid the doctor’s
office or can’t afford to go to a
doctor’s office.”

Community Perspectives continued
Maggie Dusha, ANP FNP

Dr. Marisa Friscia, MD

Kate Lawrence, MSN BSN RN

Margaret Heale, WOCN

What are some of the barriers your patients face in treating stasis dermatitis?
“The frequency of needing to be seen
by a provider or resistance to letting
someone into their home such as a
visiting nurse; the cost of treatment
can be very expensive; and it is hard
for patients in this age group to get
compression stockings on. The zipper
compression stockings are expensive
and insurance won’t give it to them at
first.”

“Being proactive, exercising, eating
the right food, low salt [diet], losing
weight, and using compression socks.”

“[Barriers are] based on cost, access,
and self-management ability.”
“Access to compression stockings and
the secondary problem is being able
to put them on. This is very
problematic for morbidly obese and
elderly patients.”

“Following through on their part;
moisturizing and not scratching.”

“The biggest barrier is compression
stockings, they are really difficult for
patients to manage.”
“There are many creams and
moisturizers out there and people try
all of that stuff. They are told they
need to moisturize their legs, but the
content of the moisturizers can be
very allergenic so finding products
that people are not sensitive to is a
huge problem.”

What are the barriers you as a provider face in counseling/managing these patients/their stasis dermatitis?
“Compliance, time (office visit length),
supplies to treat in the office.
Education-wise, there isn’t much
material that is written on this that I
can give to patients since I want to
make sure it is in language they can
understand.”

“Getting the patient back into the
office multiple times to reinforce the
importance of treatment. Follow up is
much more important than the
primary visit.”

“Access to [insurance] coverage for
garments/stockings for long term
management and patient buy in,
which takes more than a 5-10 minute
office session.”
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“Trying to convince people that they
need to change their lifestyle and
they need to be part of the solution
to the problem that they have.
We are all individuals and all have
habits that we grow into.”

Methodology
Goals of the Project
 Assess the community’s understanding of stasis dermatitis and their
awareness of its complications
 Use this information to help healthcare providers tailor their
preventative health counseling accordingly
 Provide education for patients on stasis dermatitis, its complications,
and therapies/behavioral changes to prevent disease progression

Methodology
 13 patients at Battenkill Valley Health Center between 1/1/201712/13/2017 were identified by the electronic health records as
having a diagnosis of stasis dermatitis or chronic venous insufficiency
 Stasis Dermatitis Questionnaire administered to a total of 7 of the
selected patients; 6 via telephone and 1 in person
 1 patient chose to abstain from the questionnaire
 5 patients were unable to be reached
 No identifying information was collected
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Intervention
 Developed an educational handout on stasis dermatitis for healthcare providers to distribute
to qualified patients
 Devise recommendations for future preventative counseling based on analysis of survey data
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Results & Responses
Stasis Dermatitis Questionnaire Results
 Our patient’s understanding of stasis dermatitis and its complications
 Relatively poor
 71% of patients surveyed have had symptoms of stasis dermatitis for more than 3 years, yet only 43% of patients correctly
identified all of the symptoms that would warrant a visit to a healthcare provider (pain, redness, pus-like drainage, or openwound/ulcer).

 Patients with history of complications from CVI
 57% of patients experienced at least one complication as a result of their CVI including a skin infection, skin ulcer, or bone
infection indicating poorly controlled disease within this sample population

 Patients who had been spoken to about stasis dermatitis by a healthcare provider


86% of patients stated that they had not been counseled on the complications of untreated symptoms of stasis dermatitis and
57% of patients stated they had not been counseled on ways to prevent stasis dermatitis and its progression by a healthcare
provider demonstrating an opportunity for education

 Patients who have attempted to manage their stasis dermatitis with leg elevation and/or gradient
compression stockings
 86% of patients have tried to elevate their legs for symptom relief and 71% of patients have tried gradient compression
stockings at least once to prevent symptoms

 Patients who have attempted to manage their stasis dermatitis with exercise, weight loss and/or
medication
 57% of patients exercise, 29% intentionally lost weight since the onset of their symptoms, and 29% of patients are taking
medications/treating their symptoms in some alternative way
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Results & Responses continued
Community Perspective Responses
 Unanimously providers interviewed agree that the majority of patients do not understand the potential
consequences of stasis dermatitis
 Providers generally agree that patients are initially hesitant to see a provider for worsening symptoms
of venous insufficiency and commonly only present after severe pain and ulceration has developed
 Treatment barriers for patients according to providers include: access to therapies, cost of therapies,
and self-motivation for adherence to therapies
 Treatment barriers for providers treating these patients include: patient compliance, patient follow-up,
lack of appropriate educational material, and access to insurance coverage for preventative treatment
modalities

Overall Conclusions Drawn from Results
 Providers’ perception of their patients’ understanding of stasis dermatitis and its complications
corresponds with surveyed patients’ comprehension.
 Despite most patients attempting preventative therapies, 50% had developed complications from CVI.
This was consistent with provider reflections of delayed patient presentations until severe disease had
developed. This demonstrates poorly controlled disease and room for implementing more aggressive
preventative strategies and therapies.
 The discrepancy in the patient-reported lack of provider counseling on stasis dermatitis complications
and prevention and provider-reported lack of patient compliance and follow-up suggests an
opportunity to investigate how to better educate patients in the context of an office visit with a goal of
adherence.
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Evaluation of Effectiveness & Limitations
Evaluation of Effectiveness
 This study served as a cursory glance at patient awareness of stasis dermatitis to assist providers
with preventative counseling while also developing a handout to supplement this discussion.
 This study was effective in the sense of beginning the conversation surrounding this disease, yet in
order to evaluate the true effectiveness of this study a secondary study would need to be performed
on a larger cohort of patients over a longer duration. The results of these two studies could be
compared to determine if the there is a similar trend in outcomes.

Limitations
 The size of the cohort sampled was limited to 7 participants which restricts our ability to draw
significant conclusions and generalize our findings to the population
 The patients surveyed were based on a medical record diagnoses of stasis dermatitis or CVI, which
relies on provider documentation and this is not always up to date
 Patients from only one primary care office were surveyed, introducing selection bias into our results
 Most patients were administered the Stasis Dermatitis Questionnaire over the telephone, thus
preventing clinical confirmation of stasis dermatitis/CVI prior to questionnaire completion
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Recommendation for Future Projects/Interventions
• Distribute Stasis Dermatitis handout to patients with
venous insufficiency or at risk of developing it due to
comorbid conditions
• Evaluate patients’ management of venous insufficiency over time
after being provided with this material

• Train medical assistants and nurses to assess all patients
for chronic venous disease on initial office visit intake
• Encourage providers to incorporate a lower extremity
examine into their repertoire of preventative screening
exams to assess for stasis dermatitis
• Document any signs of venous insufficiency with images in chart for
chronic evaluation

• Encourage providers to use the Venous Clinical Severity
Score (VCSS)15,16 when evaluating all patients
• Document this value in the medical records for an objective
evaluation of their chronic venous disease
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